Sign in to view content

Regulation of Epithelial-Mesenchymal Transition via RUNX1 in Proliferative Vitreoretinopathy

Leo A. Kim, MD, PhD

Video
Published 2019

Related

Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy Associated with Rhegmatogenous Retinal Detachment: The Phase II FIXER Trial
Ayman Elnahry, MD, PhD
Annual Meeting Talks
2023
Postoperative Intravitreal Methotrexate Injections Reduce Reoperations in Eyes With Proliferative Vitreoretinopathy and Diabetic Retinopathy
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2021
Single Cell Genome-Wide Expression Profiling of Patient-Derived Membranes in Proliferative Vitreoretinopathy
Leo A. Kim, MD, PhD
Annual Meeting Talks
2020

Category: Retinal Detachment

See more